4.7 Article

In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 50, Issue 12, Pages 4206-4208

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00793-06

Keywords

-

Funding

  1. NIAID NIH HHS [R37 AI034885, R01 AI034885, AI 34885] Funding Source: Medline

Ask authors/readers for more resources

Toxoplasmosis, caused by the protozoan Toxoplasma gondii, is medically important and distributed worldwide. Currently available medications are limited in terms of efficacy and side effects. We synthesized novel, nonacetal, hydrolytically stable derivatives of artemisinin and showed that they inhibit the replication of Toxoplasma gondii in cell culture.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available